Inhalation Sciences Sweden AB (publ) releases Q3 Report 2021 (Correction in Income Statement)
(Stockholm, Sweden, 24 November, 2021) Inhalation Sciences AB announces that the company's Q3 Report for 2021 (in Swedish) is now available on the company's website. For more information please visit: http://inhalation.se/investors/finansiella-rapporter/Summary of the interim report The clinical trial of PreciseInhale is ongoing and on schedule. ISAB expects to be able to present final results and a basis for publishing data within the coming months. This quarter the company has signed several large orders with both new and returning customers. The company had an order backlog of SEK